Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 320

1.

[A Case of Urethral Carcinoma in Situ Resected by Urethrectomy of Anterior Urethra].

Koh Y, Ujike T, Fujita K, Uemura M, Kiuchi H, Imamura R, Miyagawa Y, Nonomura N.

Hinyokika Kiyo. 2019 Aug;65(8):337-340. doi: 10.14989/ActaUrolJap_65_8_337. Japanese.

PMID:
31501403
2.

Importance of Multiparametric Evaluation of Immune-Related T-Cell Markers in Renal-Cell Carcinoma.

Kawashima A, Uemura M, Nonomura N.

Clin Genitourin Cancer. 2019 Aug 5. pii: S1558-7673(18)30100-9. doi: 10.1016/j.clgc.2019.07.021. [Epub ahead of print] Review.

PMID:
31473121
3.

SF3B2-mediated RNA splicing drives human prostate cancer progression.

Kawamura N, Nimura K, Saga K, Ishibashi A, Kitamura K, Nagano H, Yoshikawa Y, Ishida K, Nonomura N, Arisawa M, Luo J, Kaneda Y.

Cancer Res. 2019 Aug 20. pii: canres.3965.2018. doi: 10.1158/0008-5472.CAN-18-3965. [Epub ahead of print]

PMID:
31431456
4.

Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer.

Hayashi T, Fujita K, Matsushita M, Nonomura N.

Cancers (Basel). 2019 Aug 12;11(8). pii: E1153. doi: 10.3390/cancers11081153. Review.

5.

Correction to: Primary adrenal lymphoma: three case reports and review of Japanese cases.

Nakazawa S, Uemura M, Ujike T, Fujita K, Takao T, Miyagawa Y, Nonomura N.

Int Cancer Conf J. 2018 Sep 1;7(4):159. doi: 10.1007/s13691-018-0343-0. eCollection 2018 Oct.

6.

Evaluation of IgA1 O-glycosylation in Henoch-Schönlein Purpura Nephritis Using Mass Spectrometry.

Nakazawa S, Imamura R, Kawamura M, Kato T, Abe T, Iwatani H, Yamanaka K, Uemura M, Kishikawa H, Nishimura K, Tajiri M, Wada Y, Nonomura N.

Transplant Proc. 2019 Jun;51(5):1481-1487. doi: 10.1016/j.transproceed.2019.01.122. Epub 2019 May 10.

PMID:
31084922
7.

Adherence to Dietary Recommendations Measured by Smartphone-based Recipe Nutrition Calculator in Kidney Transplant Patients.

Ichimaru N, Kawamura M, Nakazawa S, Kato T, Abe T, Kaimori JY, Imamura R, Moriyama T, Nonomura N.

Transplant Proc. 2019 Jun;51(5):1362-1364. doi: 10.1016/j.transproceed.2019.03.021. Epub 2019 May 7.

PMID:
31076153
8.

Perinephric invasion as a prognostic factor in non-metastatic renal cell carcinoma: analysis of a nation-wide registry program.

Kume H, Homma Y, Shinohara N, Obara W, Kondo T, Kimura G, Fujimoto H, Nonomura N, Hongo F, Sugiyama T, Takahashi M, Kanayama HO, Fukumori T, Eto M.

Jpn J Clin Oncol. 2019 Apr 12. pii: hyz054. doi: 10.1093/jjco/hyz054. [Epub ahead of print]

PMID:
30977820
9.

Clinical significance of programmed death-1 and programmed death-ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma.

Mikami S, Mizuno R, Kondo T, Shinohara N, Nonomura N, Ozono S, Eto M, Tatsugami K, Takayama T, Matsuyama H, Kishida T, Oya M; Japanese Society of Renal Cancer.

Cancer Sci. 2019 Jun;110(6):1820-1828. doi: 10.1111/cas.14019. Epub 2019 May 13.

10.

Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinoma.

Hayashi Y, Fujita K, Matsuzaki K, Matsushita M, Kawamura N, Koh Y, Nakano K, Wang C, Ishizuya Y, Yamamoto Y, Jingushi K, Kato T, Kawashima A, Ujike T, Nagahara A, Uemura M, Imamura R, Takao T, Takada S, Netto GJ, Nonomura N.

Cancer Sci. 2019 May;110(5):1771-1779. doi: 10.1111/cas.14000. Epub 2019 Apr 7.

11.

Assessment of renal function in living kidney donors before and after nephrectomy: A Japanese prospective, observational cohort study.

Kakuta Y, Imamura R, Okumi M, Horio M, Isaka Y, Ichimaru N, Takahara S, Nonomura N, Tanabe K.

Int J Urol. 2019 Apr;26(4):499-505. doi: 10.1111/iju.13923. Epub 2019 Feb 28.

PMID:
30818421
12.

Obesity, Inflammation, and Prostate Cancer.

Fujita K, Hayashi T, Matsushita M, Uemura M, Nonomura N.

J Clin Med. 2019 Feb 6;8(2). pii: E201. doi: 10.3390/jcm8020201. Review.

13.

Identification of Multisialylated LacdiNAc Structures as Highly Prostate Cancer Specific Glycan Signatures on PSA.

Haga Y, Uemura M, Baba S, Inamura K, Takeuchi K, Nonomura N, Ueda K.

Anal Chem. 2019 Feb 5;91(3):2247-2254. doi: 10.1021/acs.analchem.8b04829. Epub 2019 Jan 23.

PMID:
30669833
14.

Forkhead box O1 as an indicator of prognosis is inactivated in urothelial carcinoma of the upper urinary tract.

Ide H, Jiang G, Mizushima T, Fujita K, Inoue S, Yamaguchi S, Fushimi H, Nonomura N, Miyamoto H.

Oncol Lett. 2019 Jan;17(1):482-487. doi: 10.3892/ol.2018.9510. Epub 2018 Sep 26.

15.

Adipocyte GR Inhibits Healthy Adipose Expansion Through Multiple Mechanisms in Cushing Syndrome.

Hayashi R, Okuno Y, Mukai K, Kitamura T, Hayakawa T, Onodera T, Murata M, Fukuhara A, Imamura R, Miyagawa Y, Nonomura N, Otsuki M, Shimomura I.

Endocrinology. 2019 Mar 1;160(3):504-521. doi: 10.1210/en.2018-01029.

PMID:
30649271
16.

Phenotypic Analysis of Tumor Tissue-Infiltrating Lymphocytes in Tumor Microenvironment of Bladder Cancer and Upper Urinary Tract Carcinoma.

Kawashima A, Kanazawa T, Jingushi K, Kato T, Ujike T, Nagahara A, Fujita K, Morimoto-Okazawa A, Iwahori K, Uemura M, Imamura R, Wada H, Nonomura N.

Clin Genitourin Cancer. 2019 Apr;17(2):114-124. doi: 10.1016/j.clgc.2018.11.004. Epub 2018 Nov 17.

PMID:
30555025
17.

Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients.

Nakazawa S, Imamura R, Kawamura M, Kato T, Abe T, Namba T, Iwatani H, Yamanaka K, Uemura M, Kishikawa H, Nishimura K, Oka K, Tajiri M, Wada Y, Nonomura N.

Biochem Biophys Res Commun. 2019 Jan 22;508(4):1106-1112. doi: 10.1016/j.bbrc.2018.12.014. Epub 2018 Dec 13.

PMID:
30553446
18.

Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma.

Yamamoto Y, Uemura M, Fujita M, Maejima K, Koh Y, Matsushita M, Nakano K, Hayashi Y, Wang C, Ishizuya Y, Kinouchi T, Hayashi T, Matsuzaki K, Jingushi K, Kato T, Kawashima A, Ujike T, Nagahara A, Fujita K, Imamura R, Nakagawa H, Nonomura N.

Cancer Sci. 2019 Feb;110(2):617-628. doi: 10.1111/cas.13906. Epub 2019 Jan 25.

19.

Leukocyte‑associated immunoglobulin‑like receptor 1 promotes tumorigenesis in RCC.

Jingushi K, Uemura M, Nakano K, Hayashi Y, Wang C, Ishizuya Y, Yamamoto Y, Hayashi T, Kinouchi T, Matsuzaki K, Kato T, Kawashima A, Ujike T, Nagahara A, Fujita K, Ueda K, Tsujikawa K, Nonomura N.

Oncol Rep. 2019 Feb;41(2):1293-1303. doi: 10.3892/or.2018.6875. Epub 2018 Nov 20.

PMID:
30483814
20.

Metformin inhibits prostate cancer growth induced by a high-fat diet in Pten-deficient model mice.

Hayashi T, Fujita K, Matsushita M, Hayashi Y, Uemura M, Nonomura N.

Int J Urol. 2019 Feb;26(2):307-309. doi: 10.1111/iju.13847. Epub 2018 Nov 20. No abstract available.

PMID:
30458584

Supplemental Content

Loading ...
Support Center